Lumenis partners with Mandy Moore on DED awareness

Article

The actress and singer-songwriter will serves as the brand ambassador for OptiLight, a new dry eye disease treatment.

Lumenis has launched a partnership with actress and singer-songwriter Mandy Moore as the new brand ambassador for OptiLight, the company’s bright solution for dry eyes. She is featured in a new OptiLight campaign, according to a news release.

OptiLight is the first and only light-based therapy for dry eye disease (DED) that uses a patented optimal pulse technology (OPT). It is designed to help improve DED symptoms with a series of quick, gentle, in-office treatments.

Moore’s partnership with Lumenis comes after she experienced signs and symptoms of DED. She said using OptiLight as treatment significantly improved her condition.

“I’m excited to partner with Lumenis and share how OptiLight has made a real impact on my life. For years, I suffered from dry eye disease, but I didn’t know I had it ... it was a constant frustration on the set and at home with my family,” Moore said, in a statement.

After being diagnosed wtih DED, Moore said receiving treatment from OptiLight allowed her to continue normal life.

"Now, I can focus more time on what’s important to me, rather than battling the constant nuisance and discomfort of dry eye disease, and I want to inspire other people to say, ‘I won’t just live with it,’” she said.

Learn more about OptiLight here

See more dry eye coverage

Recent Videos
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
Clark Chang, OD, MSA, MSc, FAAO, discussed the complexities of diagnosing keratoconus in his Rapid Fire presentation given at the American Academy of Optometry 2024 meeting.
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, details the ease of genetic testing when diagnosing patients or reassessing a patient's diagnosis.
Gromacki, OD, FAAO, FSLS, emphasizes that corneal GP lenses remain an important part of a contact lens specialist's armamentarium
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, discusses diagnostic confusion that can be encountered when identifying macular edema in patients.
© 2024 MJH Life Sciences

All rights reserved.